concept

NEURODEGENERATIVE DISEASES

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEURODEGENERATIVE DISEASES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4620Connections

1Hypotheses

2Analyses

50Outgoing

50Incoming

0Experiments

2Debates

Summary

NEURODEGENERATIVE DISEASES is a concept in neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with ALS, Aging, Als. Connected to 2536 entities in the SciDEX knowledge graph.

View on Wiki →

AI portrait of NEURODEGENERATIVE DISEASES

AI-generated illustration · click image to enlarge

Regenerate portrait ↻

💡 Concept Info

Name	NEURODEGENERATIVE DISEASES
Key Genes/Proteins	6-OHDA, AADC, ABCA1, ABCA7, ABCD3, ABCG2
Related Diseases	Aging
Related Pathways	Adaptive Immunity

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| NEURODEGENERATIVE_DISORDERS["NEURODEGENERATIVE DISORDERS"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| AUTOPHAGY["AUTOPHAGY"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Neurodegeneration["Neurodegeneration"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Autophagy["Autophagy"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"activates"| Apoptosis["Apoptosis"]
        APOPTOSIS["APOPTOSIS"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
        PARKINSON_S_DISEASE_2["PARKINSON'S DISEASE"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
        OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    end
    subgraph Therapeutic["Therapeutic"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"therapeutic target"| ALS["ALS"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"therapeutic target"| Als["Als"]
        PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"therapeutic target"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
        TAU["TAU"] -->|"therapeutic target"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    end
    subgraph Pathology["Pathology"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"contributes to"| Alzheimer["Alzheimer"]
        NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"] -->|"associated with"| AMYOTROPHIC_LATERAL_SCLEROSIS["AMYOTROPHIC LATERAL SCLEROSIS"]
        PARKINSON_S_DISEASE_1["PARKINSON'S DISEASE"] -->|"associated with"| NEURODEGENERATIVE_DISEASES["NEURODEGENERATIVE DISEASES"]
    end
    style NEURODEGENERATIVE_DISEASES fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NEURODEGENERATIVE_DISORDERS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Apoptosis fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AMYOTROPHIC_LATERAL_SCLEROSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOPTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE_1 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PARKINSON_S_DISEASE_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (2418)

Target	Relation	Type	Str
Autophagy	activates	pathway	1.00
Huntington	associated_with	disease	1.00
Parkinson	associated_with	disease	1.00
Parkinson	causes	disease	1.00
Als	therapeutic_target	disease	1.00
AUTOPHAGY	associated_with	gene	1.00
Als	protects_against	disease	1.00
Neurodegeneration	biomarker_for	disease	1.00
NEUROINFLAMMATION	activates	gene	1.00
NEURON	activates	gene	1.00
Neuroinflammation	associated_with	disease	1.00
Neurodegeneration	activates	disease	1.00
Autophagy	regulates	pathway	1.00
Apoptosis	activates	pathway	1.00
AGING	therapeutic_target	gene	1.00
Dementia	activates	disease	1.00
Stem Cell	therapeutic_target	pathway	1.00
Neurodegeneration	associated_with	disease	1.00
NEUROINFLAMMATION	associated_with	gene	1.00
Inflammation	regulates	disease	1.00
Als	biomarker_for	disease	1.00
Neurodegeneration	treats	disease	1.00
Parkinson	expressed_in	disease	1.00
Stroke	associated_with	disease	1.00
INFLAMMATION	associated_with	gene	1.00
Inflammation	associated_with	disease	1.00
Neuroinflammation	activates	disease	1.00
STROKE	associated_with	gene	1.00
AUTOPHAGY	activates	gene	1.00
ALS	therapeutic_target	gene	1.00
ALZHEIMER'S DISEASE	regulates	gene	1.00
Inflammation	activates	disease	1.00
NEURODEGENERATIVE DISORDERS	regulates	gene	1.00
Alzheimer	inhibits	disease	1.00
Cancer	therapeutic_target	disease	1.00
CANCER	associated_with	gene	1.00
MITOCHONDRIA	associated_with	gene	1.00
ALZHEIMER'S DISEASE	causes	gene	1.00
Alzheimer	associated_with	disease	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
Cardiovascular	associated_with	disease	1.00
Aging	associated_with	disease	1.00
AGING	associated_with	gene	1.00
Als	expressed_in	disease	1.00
NEURODEGENERATIVE DISORDERS	activates	gene	1.00
GENES	regulates	gene	1.00
ALS	associated_with	gene	1.00
ASTROCYTES	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
Alzheimer	activates	disease	1.00

Incoming (2202)

Source	Relation	Type	Str
APOPTOSIS	therapeutic_target	gene	1.00
HUNTINGTON	associated_with	gene	1.00
PARKINSON	causes	gene	1.00
HUNTINGTON	activates	gene	1.00
PARKINSON	associated_with	gene	1.00
ALZHEIMER	therapeutic_target	gene	1.00
PARKINSON'S DISEASE	causes	gene	1.00
PARKINSON	therapeutic_target	gene	1.00
NEURODEGENERATION	activates	gene	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
PARKINSON'S DISEASE	activates	gene	1.00
NEURODEGENERATION	causes	gene	1.00
ALZHEIMER	associated_with	gene	1.00
PARKINSON	regulates	gene	1.00
AUTOPHAGY	associated_with	gene	1.00
CYTOKINES	activates	gene	1.00
OXIDATIVE STRESS	therapeutic_target	gene	1.00
TAU	therapeutic_target	gene	1.00
NF-ΚB	activates	gene	1.00
ALZHEIMER	expressed_in	gene	1.00
ALZHEIMER	regulates	gene	1.00
AMPK	activates	gene	1.00
ALZHEIMER	causes	gene	1.00
OXIDATIVE STRESS	regulates	gene	1.00
OXIDATIVE STRESS	associated_with	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
PARKINSON'S DISEASE	regulates	gene	1.00
NEURODEGENERATION	treats	gene	1.00
NEURODEGENERATION	regulates	gene	1.00
CANCER	associated_with	gene	1.00
HUNTINGTON	targets	gene	1.00
ALZHEIMER	activates	gene	1.00
APOPTOSIS	regulates	gene	1.00
AUTOPHAGY	activates	gene	1.00
PARKINSON'S DISEASE	associated_with	gene	1.00
NEURODEGENERATION	associated_with	gene	1.00
ALZHEIMER	treats	gene	1.00
NEUROTOXICITY	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
PARKINSON	activates	gene	1.00
NEURODEGENERATION	targets	gene	1.00
TNF	activates	gene	1.00
TAU	activates	gene	1.00
TAU	associated_with	gene	1.00
ROS	activates	gene	1.00
NEURODEGENERATION	biomarker_for	gene	1.00
NEUROTOXICITY	therapeutic_target	gene	1.00
BDNF	activates	gene	1.00
ALZHEIMER	inhibits	gene	1.00
SIRT1	activates	gene	1.00

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
microglial priming across neurodegenerative diseases should	0.577	neurodegeneration	Microglial Priming as Upstream Causal No

Mentioning Analyses (2)

Scientific analyses that reference this entity

Autophagy-lysosome pathway convergence across neurodegenerative diseases

neurodegeneration | 2026-04-01 | 0 hypotheses

Sleep disruption as cause and consequence of neurodegeneration

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (2)

Multi-agent debates referencing this entity

What are the mechanisms underlying autophagy-lysosome pathway convergence across

closed · Rounds: 5 · Score: 0.95 · 2026-04-01

What are the mechanisms underlying sleep disruption as cause and consequence of

closed · Rounds: 4 · Score: 0.95 · 2026-04-01

Related Research

Hypotheses and analyses mentioning NEURODEGENERATIVE DISEASES in their description or question text

No additional research found